1. Home
  2. LIVE vs IFRX Comparison

LIVE vs IFRX Comparison

Compare LIVE & IFRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LIVE
  • IFRX
  • Stock Information
  • Founded
  • LIVE 1968
  • IFRX 2007
  • Country
  • LIVE United States
  • IFRX Germany
  • Employees
  • LIVE N/A
  • IFRX N/A
  • Industry
  • LIVE Other Specialty Stores
  • IFRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • LIVE Consumer Discretionary
  • IFRX Health Care
  • Exchange
  • LIVE Nasdaq
  • IFRX Nasdaq
  • Market Cap
  • LIVE 55.6M
  • IFRX 53.5M
  • IPO Year
  • LIVE N/A
  • IFRX 2017
  • Fundamental
  • Price
  • LIVE $13.80
  • IFRX $1.42
  • Analyst Decision
  • LIVE
  • IFRX Strong Buy
  • Analyst Count
  • LIVE 0
  • IFRX 5
  • Target Price
  • LIVE N/A
  • IFRX $7.40
  • AVG Volume (30 Days)
  • LIVE 8.5K
  • IFRX 754.8K
  • Earning Date
  • LIVE 12-11-2025
  • IFRX 11-07-2025
  • Dividend Yield
  • LIVE N/A
  • IFRX N/A
  • EPS Growth
  • LIVE N/A
  • IFRX N/A
  • EPS
  • LIVE 0.46
  • IFRX N/A
  • Revenue
  • LIVE $443,794,000.00
  • IFRX $191,224.00
  • Revenue This Year
  • LIVE N/A
  • IFRX N/A
  • Revenue Next Year
  • LIVE N/A
  • IFRX $1,216.24
  • P/E Ratio
  • LIVE $30.04
  • IFRX N/A
  • Revenue Growth
  • LIVE N/A
  • IFRX 54.36
  • 52 Week Low
  • LIVE $6.25
  • IFRX $0.71
  • 52 Week High
  • LIVE $25.88
  • IFRX $2.82
  • Technical
  • Relative Strength Index (RSI)
  • LIVE 28.14
  • IFRX 52.03
  • Support Level
  • LIVE $16.73
  • IFRX $1.30
  • Resistance Level
  • LIVE $16.33
  • IFRX $1.71
  • Average True Range (ATR)
  • LIVE 0.76
  • IFRX 0.16
  • MACD
  • LIVE -0.31
  • IFRX 0.00
  • Stochastic Oscillator
  • LIVE 17.41
  • IFRX 46.48

About LIVE Live Ventures Incorporated

Live Ventures Inc is a holding company for diversified businesses. It is focused on acquiring and operating profitable companies in various industries. The company operates in the business segments of Retail Entertainment which includes direct sales of entertainment and appliance products and services, Flooring Manufacturing, Steel Manufacturing, which includes the sale of steel plates, ground flat stock, and drill rods, and Corporate and Other. It derives key revenue from the Flooring Manufacturing segment which includes the manufacturing of carpets and rugs, yarn products, as well as a reseller of hard surface flooring products. Geographically the activities are carried out throughout the United States.

About IFRX InflaRx N.V.

InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.

Share on Social Networks: